tradingkey.logo
tradingkey.logo
Search

OptimizeRx Corp

OPRX
Add to Watchlist
8.950USD
-0.400-4.28%
Close 11-11 16:00(ET)
168.62MMarket Cap
24.17P/E TTM

Today

-4.28%

5 Days

-8.86%

1 Month

+8.09%

6 Months

+44.12%

Year to Date

-27.00%

1 Year

-43.68%

Key Figures

9.400Open
9.830High
47.51KVolume
24.17P/E TTM
8.02P/E Dynamic
--Dividend TTM
0.25%Turnover Ratio
9.350Prev. Close
8.850Low
442.91KTurnover
LossP/E Static
1.28P/B
0.00%Div Yield TTM
4.08%ROA
16.37052wk High
105.20Volume Ratio
-20.11MNet Profit
18.84MShares
0.3693EPS TTM
1.14Beta
5.56%ROE
4.54052wk Low
10.37%Amplitude
70.62%Gross Margin
168.62MMarket Cap
7.82Reward/Risk
4.33%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

OptimizeRx Corp's Score

-0.01vs previous score
Forecast8.67
Financial Health6.93
Technical4.13
Valuation Dimensions6.24
Institutional Confidence7.00
Risk Assessment4.19

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
12.600Target Price
+35.19%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy22222222
Buy44444444
Hold00001111
Sell00000000
Strong Sell00000000

OptimizeRx Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Neutral

OptimizeRx Corp Latest Earnings Call Transcripts

OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30%

OptimizeRx Q2 2026 revenue fell 30% to $20.5 million, while management reaffirmed its $95 million-$100 million full-year revenue guidance.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/0.17
Revenue / Forecast
--/21.19M

OptimizeRx Corp Profile

SectorSoftware & IT Services
Ticker SymbolOPRX
Number of employees106
CountryUnited States of America

Ownership

ShareholdersProportion
Whetstone Capital Advisors, LLC8.04%
Weintraub (Michael)7.38%
BlackRock Institutional Trust Company, N.A.5.76%
Royce Investment Partners4.73%
Shareholder TypesProportion
Investment Advisor35.58%
Investment Advisor/Hedge Fund22.54%
Individual Investor12.68%
Hedge Fund11.85%

FAQs

What is the current price of OptimizeRx Corp (OPRX)?

The current price of OptimizeRx Corp (OPRX) is 8.95.

What is the symbol of OptimizeRx Corp?

The ticker symbol of OptimizeRx Corp is OPRX.

What is the 52-week high of OptimizeRx Corp?

The 52-week high of OptimizeRx Corp is 16.37.

What is the 52-week low of OptimizeRx Corp?

The 52-week low of OptimizeRx Corp is 4.54.

What is the market capitalization of OptimizeRx Corp?

The market capitalization of OptimizeRx Corp is 168.62M.

Is OptimizeRx Corp (OPRX) currently rated as Buy, Hold, or Sell?

According to analysts, OptimizeRx Corp (OPRX) has an overall rating of Buy, with a price target of 12.60.

What is the Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX)?

The Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX) is 0.37.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.